Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The cytochrome P-450 enzyme system (CYP) is a superfamily of heme-containing monooxygenases crucial for the metabolism of endogenous compounds and xenobiotics, including drugs and environmental chemicals. CYPs catalyze oxidation reactions, primarily hydroxylation, increasing the water solubility of hydrophobic molecules for excretion. Genetic polymorphisms in CYP genes lead to variations in drug response, affecting efficacy and toxicity. They are central targets for understanding pharmacokinetics/pharmacodynamics.
Oxidation of substrates, making them more water-soluble for excretion. Activation of prodrugs.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytochrome P-450 Enzyme System (CYP).